Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
WAT
$360.00
Waters
$2.75
.77%
WAT
Earnings Whisper ®
N/A
3rd Quarter September 2024
Consensus: $2.68
Revenue: $887.79 Mil
Friday
Nov 1
6:50 AM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Wednesday, July 31, 2024
Waters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results
What do you expect when WAT reports earnings?
Beat
Meet
Miss
Where is WAT's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$370.99
$367.79
$363.90
$360.70
Support
$356.80
$353.60
$349.71
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division.
Peers
Boston Scientific
Stryker
Abbott
Becton, Dickinson
3M
Teleflex
ResMed
Baxter International
Integra LifeSciences Holdings
Merit Medical Systems
Expectations
›
Waters